A Phase 1b/2a Study of CTO1681 for the Prevention and Treatment of Cytokine Release Syndrome in Patients with Diffuse Large B-cell Lymphoma Receiving CAR T-cell Therapy
Clinical Trial Grant
Awarded By
CytoAgents, Inc.
Start Date
April 26, 2024
End Date
April 30, 2029
Awarded By
CytoAgents, Inc.
Start Date
April 26, 2024
End Date
April 30, 2029